Wisp Acquires TBD Health, Pivoting to Hybrid Women's Healthcare

NEW YORK, NY – January 27, 2026 – Wisp, the largest direct-to-consumer women’s telehealth company in the United States, has announced its first-ever acquisition, purchasing the national sexual health platform TBD Health. The move signals a significant strategic pivot for Wisp, expanding its operations beyond its consumer-facing roots into the complex worlds of enterprise partnerships and hybrid care models that blend virtual and in-person services.

The acquisition, the financial terms of which were not disclosed, integrates TBD Health's robust 50-state infrastructure for diagnostics, virtual clinical support, and TelePrEP services into Wisp’s extensive platform, which already serves 1.8 million patients. This combination creates a formidable entity aimed squarely at addressing long-standing gaps in the American healthcare system, particularly in preventative sexual health for women.

A Strategic Pivot Beyond Direct-to-Consumer

For years, Wisp has been a dominant force in the direct-to-consumer (DTC) telehealth space, offering discreet online access to treatments for a range of women’s health needs, from birth control to menopause. However, this acquisition marks a deliberate evolution. Industry observers note that while DTC models have successfully lowered barriers to care for millions, their growth can be limited. The next frontier for digital health lies in integrating with the established, albeit often fragmented, broader healthcare ecosystem.

By acquiring TBD Health, Wisp is moving up the healthcare value chain. Instead of solely competing for individual patient transactions, it is now positioned to offer turnkey sexual health solutions to large-scale partners, including hospital systems, public health organizations, and corporate employers. This strategy reflects a maturing telehealth market where deep integration, rather than simple disruption, is becoming the new benchmark for success.

“This acquisition reflects where healthcare is going and where women have been left behind,” said Monica Cepak, CEO of Wisp, in a statement. “TBD Health brings the infrastructure and partnerships that allow us to move into hybrid and enterprise care quickly, while staying true to Wisp’s patient-first approach.”

This strategic shift is further contextualized by Wisp's ownership. The company is majority-owned by WELL Health Technologies Corp., a Canadian firm known for its aggressive and successful growth-by-acquisition strategy in the healthcare technology sector. Wisp's first acquisition aligns with its parent company's playbook, suggesting this is the first of many potential moves to consolidate its market position and expand its service offerings.

Targeting a Critical Public Health Gap

The most immediate impact of the merger is poised to be in the realm of preventative sexual health, specifically concerning HIV. The press release highlighted a staggering public health shortfall: of the 2.4 million people in the U.S. eligible for PrEP (Pre-Exposure Prophylaxis), a medication that is 99% effective at preventing HIV through sexual contact, only about 25% are currently enrolled for treatment.

This gap is particularly pronounced among women. Despite accounting for 19 percent of new HIV diagnoses, women have been historically underserved by prevention models largely designed and marketed for men. The Wisp-TBD Health entity aims to change that.

“Together, we are making preventative care more accessible especially to women and integrating them into proven care models,” Cepak added. TBD Health brings a nationally scaled TelePrEP infrastructure and critical partnerships with trusted institutions like Mount Sinai Health System, the San Francisco AIDS Foundation, and Planned Parenthood Direct. These relationships are crucial for building care pathways that are not only accessible but also affordable and trusted by patients, helping to dismantle the cost and stigma barriers that often prevent individuals, particularly women and people of color, from seeking preventative care.

The Future is Hybrid: Integrating Digital and Physical Care

This deal is a prime example of the next evolution in telehealth: the hybrid care model. The limitations of purely virtual care become apparent when diagnostics, lab work, or in-person consultations are required. The Wisp and TBD Health combination seeks to solve this by creating a seamless continuum of care.

A patient might begin their journey on Wisp’s digital platform but then be directed to TBD Health’s network for STI testing or a PrEP consultation that integrates with a local clinic. This integrated approach ensures that patients don't fall through the cracks when navigating between virtual and physical care settings.

Daphne Chen, Co-Founder of TBD Health, emphasized this integration. "By joining forces with Wisp, we can provide partners with a turnkey solution for PrEP along with sexual health diagnostics and care that integrates seamlessly into their existing workflows, ensuring no patient falls through the cracks,” she stated. This B2B focus is a core component of the new strategy, leveraging TBD Health's established relationships and infrastructure.

Reshaping the Competitive Landscape

The acquisition solidifies Wisp's position as a market leader and puts pressure on competitors in the crowded digital health space. Companies focused solely on a narrow range of DTC services may find it difficult to compete with an integrated provider that can offer a comprehensive suite of services spanning digital consultations, at-home diagnostics, and connections to in-person care through enterprise partnerships.

Stephanie Estey, Co-Founder of TBD Health, noted the strategic fit, stating, "Wisp is the only digital health company with the scale and trust to take our enterprise vision to the next level." This sentiment underscores the value of Wisp's 1.8 million-patient user base as a foundation for launching these new, integrated services.

Looking ahead, Wisp has been clear that this is just the beginning. The company has stated its intent to pursue other strategic M&A opportunities to fuel growth and expand into new areas of health and modalities of care. As Wisp heads into 2026, this acquisition positions it to bridge the often-siloed worlds of consumer health, enterprise systems, and public health initiatives at a national scale.